# OnCo record hcc-early (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/hcc-early/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "hcc-early" ;
  schema:name "Early hepatocellular carcinoma (BCLC 0 and A)"@en ;
  schema:alternateName "Very early HCC (BCLC 0)"@en, "Early-stage HCC (BCLC A)"@en, "Resectable hepatocellular carcinoma"@en, "HCC within Milan criteria"@en ;
  schema:description "Early hepatocellular carcinoma means a single tumour, or up to three small ones, in a liver that still works, without spread or vein invasion. It is treated to cure: cutting out the tumour, destroying it with heat through a needle, or replacing the liver by transplant, chosen by tumour size, liver function and portal pressure."@en ;
  schema:url <https://onco.cc/cancers/hcc-early/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hepatocellular_carcinoma> ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/34801630/>, <https://www.nejm.org/doi/full/10.1056/NEJM199603143341104>, <https://pubmed.ncbi.nlm.nih.gov/37871608/>, <https://en.wikipedia.org/wiki/Hepatocellular_carcinoma> ;
  onco:tag "subtype-page" ;
  onco:pipeline <https://onco.cc/trials/imbrave050/>, <https://onco.cc/technologies/liver-transplant-oncology/>, <https://onco.cc/ideas/idea-hcc-io-before-transplant/>, <https://onco.cc/ideas/idea-hcc-blood-surveillance/>, <https://onco.cc/technologies/hcc-surveillance/>, <https://onco.cc/technologies/hifu-histotripsy/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:standardOfCare <https://onco.cc/terms/hepatectomy/>, <https://onco.cc/technologies/thermal-ablation/>, <https://onco.cc/terms/radiofrequency-ablation/>, <https://onco.cc/terms/microwave-ablation/>, <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/terms/bclc-staging/>, <https://onco.cc/technologies/liver-transplant-oncology/>, <https://onco.cc/terms/bridging-therapy/>, <https://onco.cc/technologies/tace/>, <https://onco.cc/technologies/thermal-ablation/>, <https://onco.cc/technologies/sbrt/>, <https://onco.cc/technologies/radioembolisation-tare/>, <https://onco.cc/trials/imbrave050/>, <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/technologies/hcc-surveillance/>, <https://onco.cc/terms/hbv-hcv/>, <https://onco.cc/technologies/hcc-surveillance/>, <https://onco.cc/technologies/ultrasound/>, <https://onco.cc/terms/afp/>, <https://onco.cc/technologies/mri/> .